| AI | aromatase inhibitors |
| ALDH+ | aldehyde dehydrogenase positive |
| ARG-1 | arginase-1 |
| BC | breast cancer |
| BCs | breast cancer cells |
| BCSCs | breast cancer stem cells |
| bHLH | Hes/Hey family of basic helix–loop–helix |
| CAFs | cancer-associated fibroblasts |
| CBF-1 | centromere binding factor 1 |
| CCL17 | C-C motif chemokine ligand 17 |
| CCL2 | C-C motif chemokine ligand 2 |
| CCL22 | C-C motif chemokine ligand 22 |
| CCND1 | cyclin D1 |
| CCR2 | C-C chemokine receptor type 2 |
| CDKI | cyclin-dependent kinase inhibitor |
| ChemoR | chemokines receptors |
| CSCs | cancer stem-like cells |
| CSF-1 | colony stimulating factor-1 |
| DCIS | ductal carcinoma in situ |
| E2 | estradiol |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EMT | epithelial mesenchymal transition |
| ER | estrogen receptor |
| ER+ | estrogen receptor alpha positive |
| ER− | estrogen receptor alpha negative |
| ErbB1 | human epidermal growth factor receptor |
| ErbB2 | human epidermal growth factor receptor 2 |
| ErbB3 | human epidermal growth factor receptor 3 |
| ERα | estrogen receptor alpha |
| GFRs | growth factor receptors |
| GFs | growth factors |
| GPER | G protein-coupled estrogen receptor 1 |
| GSIs | γ-secretase inhibitors |
| GSK3-β | glycogen synthase kinase 3 beta |
| HER2 | human epidermal growth factor receptor 2 |
| HER2+ | human epidermal growth factor receptor 2 positive |
| HIF-1α | hypoxia-inducible factor 1 alpha |
| HIF-2α | hypoxia-inducible factor 2 alpha |
| IL-10 | interleukin-10 |
| IL-1β | interleukin-1 beta |
| IL-4 | interleukin-4 |
| IL-6 | interleukin-6 |
| IRF8 | interferon regulatory factor 8 |
| JAG | membrane-bound ligands Jagged |
| LN | lymph nodes |
| LPS | lipopolysaccharide |
| MAML | mastermind-like |
| MAPK | mitogen-activated protein kinase |
| MMP-2 | matrix metalloproteinase-2 |
| MMP-9 | matrix metalloproteinase-9 |
| MMPs | matrix metalloproteinases |
| MMTV | mouse mammary tumor virus |
| MSCs | mesenchymal cells |
| NF-κB | nuclear factor kappa B |
| NECD | Notch extracellular domain |
| NICD | Notch intracellular domain |
| NRG1 | neuregulin 1 |
| Oct-4 | octamer binding transcription factor 4 |
| PA | plasminogen activator |
| PD1+ | programmed death 1 positive |
| PR | progesterone receptor |
| PR+ | progesterone receptor positive |
| PTEN | phosphatase and tensin homolog |
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
| SDF-1 | stromal cell-derived factor-1 |
| STAT1 | signal transducer and activator of transcription 1 |
| TAMs | tumor-associated macrophages |
| TGF-β | transforming growth factor beta |
| TILs | tumor-infiltrating lymphocytes |
| TME | tumor microenvironment |
| TNBCs | triple negative breast cancers |
| TNF-α | tumor necrosis factor alpha |
| uPA | urokinase-type plasminogen activator |
| VEGF | vascular endothelial growth factor |
| VEGFR3 | VEGF receptor 3 |
| VEGFRs | vascular endothelial growth factor receptors |